Participants 138 175 4
Resected stage III cutaneous melanoma
Participants 226 334 7
patients with resected stage III melanoma administered active specific immunotherapy and low-dose interferon
Participants 433 535 6
Ad Hoc Melanoma Working Group of 25 investigators treated 604 patients from April 1997 to January 2003
